glp vs tirzepatide Semaglutide Research Comparison Tirzepatide vs. Semaglutide: What You

Female participants averaged 25.3% weight loss compared to 22.8% for males at the 12mg dose over 48 weeks

Lost wages: Compensation for the time missed from work due to illness, treatment, and recovery

Including evidence-based discussion helps clarify where semaglutide is well established and where research is still developing

doi: 10.1210/jc.2016-2466 42 MosbahHVantyghemMCNobecourtEAndreelliFArchambeaudFBismuthEet al

The only contraindications in its labeling are a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2, and serious hypersensitivity to semaglutide or its excipients